Much further work is required in large, multi-centre studies by independent research groups if robust biomarkers for prostate cancer are ever to be found considering the past failures to corroborate initially “promising” biomarkers, with PSA and sarcosine being prime examples. Here, KLK3 is linked to prostate cancer.